The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA (ctDNA) analysis by low-coverage whole genome sequencing (lcWGS) of resectable esophageal adenocarcinoma (rEAC) patients.
 
Tom van den Ende
No Relationships to Disclose
 
Aafke Creemers
No Relationships to Disclose
 
Ymke van der Pol
No Relationships to Disclose
 
Dries Boers
Consulting or Advisory Role - Janssen Vaccines (I)
 
Mark I. Van Berge Henegouwen
Consulting or Advisory Role - Alesi Surgical (Inst); Johnson & Johnson (Inst); Medtronic (Inst); Mylan (Inst)
Research Funding - Olympus (Inst); Stryker (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson
 
Suzanne S. Gisbertz
No Relationships to Disclose
 
E. Debby Geijsen
No Relationships to Disclose
 
Maarten C.C.M. Hulshof
No Relationships to Disclose
 
Frederike Dijk
No Relationships to Disclose
 
Nicole C.T. van Grieken
Consulting or Advisory Role - BMS (Inst); Merck (Inst)
 
D. Michiel Pegtel
Leadership - ExBiome
Stock and Other Ownership Interests - ExBiome
Consulting or Advisory Role - Takeda Science Foundation
Research Funding - Prediction biosciences; Takeda
Patents, Royalties, Other Intellectual Property - Exomes
Travel, Accommodations, Expenses - Takeda
 
Sarah Derks
No Relationships to Disclose
 
Maarten F. Bijlsma
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - SERVIER
 
Florent Moulière
Patents, Royalties, Other Intellectual Property - Cancer Research UK Technologies
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Nordic Group; Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca